Processing .....please wait.. 
The article has been forwarded.... 
USFDA approves Auribindo Pharma unit
By agencies
|
Wednesday, 04 May 2005, 19:30 IST
NEW DELHI:Hyderabad based Aurobindo Pharma has got USFDA approval for its Unit VIII facility located at Gaddapotharam in Andhra Pradesh to manufacture active pharmaceutical ingredients (APIs) for the U.S. market.
The company informed Bombay Stock Exchange that the U.S. Department of Health and Human Science has approved Unit VIII facility of the company as a site to manufacture APIs for the American market.
Unit VIII consists of four production blocks, of which three are geared for APIs for regulated markets in anti-retrovirals, anti-allergics and cardiovascular segments, it said.
This is the third approval for the company given by USFDA, its other approvals being Unit I for APIs and Unit III for formulations, it added.